FIBO returned to Cologne in April 2026, and the energy on the floor was different from what many expected. The event has always been synonymous with performance, aesthetics and athletic innovation. But this year, nutrition science felt far more central to the conversations than in previous editions. 

Beyond Performance

FIBO has traditionally been a fitness industry event. Athletes, supplement brands, equipment manufacturers. But in April 2026, the conversations were shifting. Functional benefits beyond pure performance, recovery, longevity, metabolic health and overall wellbeing, were driving product development across the floor.

Healthy snacking was everywhere. Brands were not just competing on taste or convenience. They were competing on ingredient quality, formulation rationale and clinical credibility. The question being asked was no longer “what does this product contain?” but “why was it formulated this way, and what does it actually do?”

Science-Backed Ingredients Are Becoming the Expectation

One of the clearest signals at FIBO 2026 was the shift in how brands are positioning their ingredients. Single-ingredient claims are losing ground. Combined formulations with a clear scientific rationale behind them are gaining traction.

Credibility has become a differentiator, from sourcing transparency to the strength of claims. Brands that could point to genuine science behind their formulations stood out.

We are seeing the same shift across the nutraceutical industry more broadly. Consumers and retail partners are becoming more demanding. The standard for what counts as evidence is rising.

Longevity Enters the Conversation

Perhaps the most striking development at FIBO 2026 was how prominently longevity featured, not just as a wellness concept, but as a strategic category. Prevention, performance health and personalised health services were being discussed alongside traditional fitness and supplement offerings.

Nutrition was central to this conversation. Personalised nutrition and longevity food concepts are moving from niche to mainstream. The gut microbiome, metabolic health and recovery nutrition are increasingly being positioned not as add-ons but as foundations.

What FIBO Confirmed for Us

At Enbiosis, we attended FIBO 2026 with a clear focus: understanding what will shape the next generation of nutritional supplements.

What we saw confirmed what we are building. The industry is moving toward formulations designed around specific biological outcomes, backed by clinical evidence, and built around the individual rather than the average consumer. Ingredient lists alone are no longer enough. Getting the biology right and having the evidence to back it up. That is what the market is starting to demand.

Our Digital Twin and AI-powered platform engineers food-grade nutraceutical formulations around defined metabolic targets, validated through peer-reviewed research. The conversations at FIBO made clear that this is the direction the market is heading.

The Standard Is Shifting

FIBO 2026 brought together health, fitness and longevity under one roof. The Longevity and Hospitality Summit reinforced what was visible across the main floor: the industry is thinking beyond single categories. Nutrition, recovery, personalised health and metabolic wellness are coming together in a way the industry has not seen before.

The question is no longer whether science matters in formulation. It is whether the science is specific enough, the evidence strong enough, and the biological rationale clear enough to stand behind.

This is exactly the standard Enbiosis is built around. FIBO 2026 confirmed that the industry is moving in the same direction.